The interaction of KRT8 with the CFTRΔF508 mutant, the most common mutation in patients with cystic fibrosis, at nucleotide-binding domain 1 (NBD1) inhibits the translocation of CFTR to the cell surface [35,36]. This evidence concerns the gene CFTR and cystic fibrosis.